Asian markets lag as oil stocks slip further
Nikkei up slightly, while Chinese indexes mixed
All Posts in "Markets"
Square’s $25 million investment in Eventbrite has more than doubled in value
Eventbrite’s first earnings report on Monday could draw the interest of one particular company: Square.
As Amarin stock drops, CEO says investors should ‘understand our data better’
Amarin CEO John Thero shrugged off the stock’s decline on Monday, telling media that any investor concerned about its latest clinical trial should take a better look at the data.
Facebook shares close at lowest price since April 2017 as tech stocks plunge
Facebook shares closed at their lowest price in 19 months, and have now plunged 35 percent from their peak in July.
Oil helps European stocks rise while tobacco goes up in smoke
European shares bounced back on Monday thanks to strong oil stocks, while tobacco firms were dented by new signs of regulators tightening the screws on menthol cigarettes.
Lawsuits, accusations fly as Florida begins arduous recount process
Palm Beach County warns it may not meet Thursday deadline
Alibaba racks up record $30.8 billion in Singles Day shopping
Jack Ma hands cedes center stage CEO Daniel Zhang at gala
When Big Brother is in your phone, in your car, everywhere
The danger of artificial intelligence isn’t the loss of jobs, it’s the loss of privacy
Asian markets largely rally after weak start, led by Chinese stocks
Nikkei back in positive territory
GE stock closes at 9-year low after JPMorgan warns worst yet to come
Analyst Stephen Tusa says latest numbers are worse than expected on almost all fronts
Despite cash infusion, Windtree still faces money running out within a year
Pain medicine biotech Latigo taps CRO founder for CMO role
Johnson & Johnson to buy heart failure implant company V-Wave for up to $1.7B
Talus Bio tacks on $11M to target hard-to-reach transcription factors
Pathalys raises $105M series B to prepare Japan-approved kidney disease drug for FDA
Denmark’s Adcendo signs $1B biobuck deal for Multitude’s anti-TF ADC
Merck & Co. bags one Kelun ADC for $37.5M, boots out another asset as pipeline tinkering continues
Avantor sells clinical services unit to private equity firm for $650M
‘We’re pretty prolific’: Lilly Catalyze360 looks to connect with emerging biotechs across ‘all areas’
FDA clears its first at-home blood test for syphilis